Cell death resistance in colon and lung cancer is mediated by ROS-signaling to the canonical NFκB pathway [14, 18], whereas in breast and ovarian cancer the mechanism linking IF1 to the cell-death resistant phenotype remains to be investigated [18]. Here, ATP5IF1 is linked to ovarian carcinoma.